Literature DB >> 30127572

Acral Hyperpigmentation Resulting from Hydroxyurea Therapy in Primary Myelofibrosis.

Apichat Kaewdech1, Kumpol Aiempanakit1, Benjawan Apinantriyo2.   

Abstract

Entities:  

Year:  2018        PMID: 30127572      PMCID: PMC6081341          DOI: 10.1007/s12288-018-0940-2

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  2 in total

1.  Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients.

Authors:  B Kumar; A Saraswat; I Kaur
Journal:  Clin Exp Dermatol       Date:  2002-01       Impact factor: 3.470

2.  Melanonychia and skin hyperpigmentation with hydroxyurea therapy.

Authors:  Sankha Koley; Sanjiv Choudhary; Atul Salodkar
Journal:  Indian J Pharmacol       Date:  2010-02       Impact factor: 1.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.